Search Results

discovery begins. << Back to podcast list Strategic Partner(s) Michel Bouvier: BRET, Biased Agonism, Michel Bouvier has spent his career building the tools to show why. ABOUT THE GUEST Michel Bouvier is CEO of the Institut de Recherches Cliniques de Montreal (IRCM) and Michel Bouvier Michel Bouvier is a professor of Biochemistry and Molecular Medicine and the CEO of the Michel Bouvier on the web Wikipedia IRIC Bouvier Lab Google Scholar Pubmed ResearchGate Twitter LinkedIn

Strong education with a Doctor of Philosophy (Ph.D.) in biochemistry under the supervision of Michel Bouvier at Université de Montréal, followed by a Postdoctoral Fellow at Scripps Research in San Diego

Michel Bouvier .

Michel Bouvier (1985) Dr. Kathleen Caron - Co-host- (1970) Dr. Richard Cerione (1985) Dr.

Michel Bouvier's lab on BRET-based conformational readouts. Berchiche didn't get in Michel Bouvier's lab led her to Nikolaus Heveker's newly opened lab at CHU Sainte-Justine Michel Bouvier’s class as an undergraduate student at the University of Montreal in early 2000.

Fellowship from the Canadian Institutes of Health Research in 2012, Bianca joined the research group of Prof Michel Bouvier at Université de Montréal. As part of Bouvier’s team, Bianca used Bioluminescence Resonance Energy Transfer (BRET)-based technology

transitioned from biophysics and protein folding to cannabinoid receptor research, guided by key mentors like Michel Bouvier.

Piñeyro, a physician-turned-pharmacologist whose early project in Michel Bouvier's lab felt like "torture de Montigny, working on serotonin and antidepressant mechanisms, and her postdoctoral training with Michel Bouvier at the Université de Montréal, where she shifted into opioid receptors. McGill: the cold email that changed a career 04:40 — The closed door that opened another: landing in Bouvier's

Michel Bouvier accepted to open our session and will be followed by Dr. John McCorvy , Dr.

Michel Bouvier at the University of Montreal. Journey, Multiplexing Assays, and Collaboration Badr shared his learning process and early tasks at Michelle

channel biology at the University of Toronto, he transitioned to GPCRs during his postdoctoral work with Michel Bouvier.

Michelle Halls reveals how organized GPCR signaling drives assay innovation and new therapeutic insights Michelle Halls In this episode Dr. Michelle Halls shares how dissecting the spatial organization of GPCR signaling opens new doors in drug About the Guest Michelle Halls is an Associate Professor at Monash University and Deputy Theme Leader More about Michelle Halls Monash Institute of Pharmaceutical Sciences Bluesky LinkedIn Articles about

Michael Feigin About Dr. Michael Feigin "Dr. Michael Feigin is an Associate Professor in the Department of Pharmacology and Therapeutics, and Director Michael Feigin on the web Roswell Park Feigin Lab Google Scholar LinkedIn Twitter Dr.

including a newly accepted BRET-based platform for beta-1 adrenergic receptor signaling built with the Bouvier pharmacological modulation, and long-running collaborations on beta-adrenergic receptor biology with the Bouvier adrenergic receptor paper — a BRET-based platform for capturing downstream signaling, built with the Bouvier

Michael Lemieux & Dr. Jason Nasse About Dr. Michael Lemieux ''My name is Michael (Mike) Lemieux and I am a Connecticut native. Michael Lemieux on the web Addgene Blog Dr. GPCR Ecosystem About Dr. Jason Nasse Dr.

Hartmut Michel . Fascinated by GPCRs he wrote to Dr.

Bryan Roth is the Michael Hooker Distinguished Professor of Pharmacology at the University of North Carolina Bryan Roth is the Michael Hooker Distinguished Professor of Pharmacology at the University of North Carolina

Michael Caterina's lab studying the role of PNS chloride transporters in neuropathic pain.

Her training began in zoology and neurobiology in Salzburg, followed by a PhD on GPCRs in Michael Freissmuth's

She then spent five years training as a postdoctoral fellow in the laboratory of Michael Caplan at Yale